Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lora C. Robosky is active.

Publication


Featured researches published by Lora C. Robosky.


Journal of Lipid Research | 2008

Quantitative evaluation of sebum lipid components with nuclear magnetic resonance

Lora C. Robosky; Kimberly Wade; Dayna Woolson; John David Baker; Matthew L. Manning; Douglas A. Gage; Michael D. Reily

A NMR spectroscopic method is described that enables the quantitation of specific lipid classes and components, independent of fatty acid composition. We demonstrate this method for measuring cholesterol, squalene, and pools of sterol esters, wax esters (WEs), and triglyceride (TG) components in sebum and meibum. When 600 MHz NMR equipment is used in conjunction with highly sensitive cryogenically cooled probes, this method has adequate sensitivity, and for some applications, advantages over commonly used HPLC-evaporative light-scattering detection and mass spectrometry-based approaches. This method is shown to be useful for preclinical and clinical monitoring of the efficacy of sebum-reducing agents in animals and humans. In Syrian hamsters, 3% topical flutamide and 20 mg/kg oral isotretinoin reduced sterol esters by 18.7% and 30.0%, respectively, and reduced WEs by 32.9% and 31.8%, respectively, as measured in a punch biopsy of the ear. In a 72 patient clinical methodology study, the assay delivered reproducible and noninvasive measurements of WEs, cholesteryl esters, TGs, and squalene from Sebutape® skin blots. The quantitative results of sebum analysis obtained by the NMR method correlate well with those obtained with HPLC-based approaches. This approach may be broadly applicable to cases in which fatty acid-independent quantification of lipid classes is desired.


International Journal of Pharmaceutics | 2009

Comparison of artificial sebum with human and hamster sebum samples.

Guang Wei Lu; Satyanarayana Valiveti; Julie Spence; Christine Zhuang; Lora C. Robosky; Kimberly Wade; Ann Love; Lain-Yen Hu; David Pole; Matt Mollan

To understand drug delivery to the sebum filled hair and sebaceous follicles, it is essential to use an artificial sebum as a surrogate of the human sebum for the investigation of drug transport properties. Artificial sebum L was developed in-house based on the chemical similarity to human sebum. The partition and diffusion of model compounds (ethyl 4-hydroxybenzoate, butyl 4-hydroxybenzoate, and hexyl 4-hydroxybenzoate) were measured in human sebum, hamster ear and body sebum (a commonly used animal model), and four representative artificial sebum samples (N, S, F, and L) in which artificial sebums, N, S and F were selected based on the available literature. DSC and NMR studies were also conducted on all sebums to compare their melting properties and chemical compositions. In vitro studies show that the partition coefficients of the three model compounds in artificial sebum L were similar to that of human sebum, whereas the hamster ear and body sebum, and other three artificial sebum samples were different from that of human sebum. Additionally, the in vitro sebum flux (microg/(cm(2)min) of three model compounds through artificial sebum L was closer to that of human sebum when compared with the other three artificial sebum (N, S and F), hamster body and hamster ear sebum. The results of this study indicate that the artificial sebum L could be used as an alternative to human sebum, as the physicochemical properties of this artificial sebum is relatively similar to human sebum.


Toxicological Sciences | 2005

Metabonomic Identification of Two Distinct Phenotypes in Sprague-Dawley (Crl:CD(SD)) Rats

Lora C. Robosky; Dale F. Wells; Laura A. Egnash; Matthew L. Manning; Michael D. Reily; Donald G. Robertson


Combinatorial Chemistry & High Throughput Screening | 2002

In Vivo Toxicity Screening Programs Using Metabonomics

Lora C. Robosky; Donald G. Robertson; J. David Baker; Sarika Rane; Michael D. Reily


Toxicology and Applied Pharmacology | 2002

Effect of dexamethasone on the metabonomics profile associated with phosphodiesterase inhibitor-induced vascular lesions in rats.

Rabih M. Slim; Donald G. Robertson; Mudher Albassam; Michael D. Reily; Lora C. Robosky; Lloyd A. Dethloff


Journal of the American Chemical Society | 2006

DFTMP, an NMR Reagent for Assessing the Near-Neutral pH of Biological Samples

Michael D. Reily; Lora C. Robosky; Matthew L. Manning; Andrew Butler; John David Baker; R. Thomas Winters


Chemical Research in Toxicology | 2007

Metabonomic evaluation of schaedler altered microflora rats

Cynthia M. Rohde; Dale F. Wells; Lora C. Robosky; Matthew L. Manning; Charles B. Clifford; Michael D. Reily; Donald G. Robertson


Analytical and Bioanalytical Chemistry | 2007

Improving NMR sensitivity by use of salt-tolerant cryogenically cooled probes

Lora C. Robosky; Michael D. Reily; Daina Avizonis


Toxicological Sciences | 2006

Communication Regarding Metabonomic Identification of Two Distinct Phenotypes in Sprague-Dawley (Crl:CD(SD)) Rats

Lora C. Robosky; Dale F. Wells; Laura A. Egnash; Matthew L. Manning; Michael D. Reily; Donald G. Robertson


Chemical Research in Toxicology | 2007

Metabonomic Evaluation of Metabolic Dysregulation in Rats Induced by PF 376304, a Novel Inhibitor of Phosphoinositide 3-Kinase

Donald G. Robertson; Kaushik Datta; Dale F. Wells; Laura A. Egnash; Lora C. Robosky; Matt Manning; Cynthia M. Rohde; Michael D. Reily

Collaboration


Dive into the Lora C. Robosky's collaboration.

Researchain Logo
Decentralizing Knowledge